[Vardenafil (levitra): new aspects of clinical efficacy].

Abstract

Vardenafil (levitra, Bayer Schering Pharna, Germany) is a 5-phosphodiesterase inhibitor which proved highly effective and safe in the treatment of erectile dysfunction. Special techniques were used to study sexual satisfaction of female partners of men treated with vardenafil. It was found that vardenafil raises significantly sexual satisfaction of female partners of men treated with vardenafil and prolongs erection. This is a new aspect of vardenafil efficacy.

• Authors: S I Gamidov, V V Iremashvili, A A Pavlovichev, O Kh Tazhetdinov
• Journal: Urologiia (Moscow, Russia : 1999) (Urologiia) 2010 Nov-Dec Issue 6 Pg. 44-7 ISSN: 1728-2985 [Print] Russia (Federation)
• PMID: 21427994 (Publication Type: English Abstract, Journal Article)

Chemical References

• Imidazoles
• Phosphodiesterase 5 Inhibitors
• Piperazines
• Sulfones
• Triazines
• Vardenafil Dihydrochloride

Topics

• Erectile Dysfunction (drug therapy)
• Humans
• Imidazoles (administration & dosage, pharmacology, therapeutic use)
• Male
• Penile Erection (drug effects)
• Personal Satisfaction
• Phosphodiesterase 5 Inhibitors (administration & dosage, pharmacology, therapeutic use)
• Piperazines (administration & dosage, pharmacology, therapeutic use)
• Quality of Life
• Sulfones (administration & dosage, pharmacology, therapeutic use)
• Treatment Outcome
• Triazines (administration & dosage, pharmacology, therapeutic use)
• Vardenafil Dihydrochloride